PIK3R2 and rheumatoid arthritis: Here, miR-30-5p was identified to be overexpressed in 80% (32 of 40) of the clinical RA tissues examined and verified that the miR-30-5p inhibitor was a potent reagent that relieved RA through PIK3R2 pathways.